Starting from August 1, 2022, TIPO Will Implement WIPO Standard ST.26 for Nucleotide and/or Amino Acid Sequence Listings Disclosed for Invention Patent Applications
2022/07/18 TaiwanWIPO has announced that the WIPO Standard ST.26 applies to international applications with nucleotide and/or amino acid sequence listing filed on or after July 1, 2022.
TIPO will fully implement WIPO Standard ST.26 from August 1, 2022. All nucleotide and/or amino acid sequences presented in invention patent applications must comply with the new Standard.
In addition, to facilitate the needs of those filing international patent applications, TIPO shall accept all applications between July 1 and 31, 2022, even if the disclosed sequences do not comply with the new Standard. TIPO has published a Q&A on the new listing requirements of WIPO Standard ST.26 on its website for public reference
“Implementation of WIPO Standard ST.26” Q&A (Mandarin)
Intellectual Property Office Ministry of Economic Affairs, R.O.C.
